PUBLICACIONES CIENTÍFICAS 2018

PUBLICACIONES DEL EQUIPO DE TRABAJO

No. ARTÍCULO
1.

González-González E, Camacho-Sandoval R, Jiménez-Uribe A, Montes-Luna A, Cortés-Paniagua I, Sánchez-Morales J, Muñoz-García L, Tenorio-Calvo AV, López-Morales CA, Velasco-Velázquez MA, Pavón L, Pérez-Tapia SM, Medina-Rivero E. Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region. J Immunol Methods. 2018 Nov 2. pii: S0022-1759(18)30207-2. doi: 10.1016/j.jim.2018.11.002. [Epub ahead of print] PubMed PMID: 30395815.

 

No. ARTÍCULO
2.

Velasco-Velazquez MA, Velazquez-Quesada I, Vasquez-Bochm LX, Perez-Tapia SM. Targeting Breast Cancer Stem Cells: a methodological perspective. Curr Stem Cell Res Ther. 2018 Aug 21. doi: 10.2174/1574888X13666180821155701. [Epub ahead of print] PubMed PMID: 30147014.

 

No. ARTÍCULO
3.

López-Morales CA, Tenorio-Calvo A, Cruz-Rodríguez R, Sánchez Y Tepoz J, Belgharbi L, Pérez-Tapia SM, Medina-Rivero E. Regulatory Pathway for Licensing Biotherapeutics in Mexico Front Med (Lausanne). 2018 Sep 25;5:272. doi: 10.3389/fmed.2018.00272. eCollection 2018

 

No. ARTÍCULO
4.

Camacho-Sandoval R, Sosa-Grande EN, González-González E, Tenorio-Calvo A, López-Morales CA, Velasco-Velázquez M, Pavón-Romero L, Pérez-Tapia SM, Medina-Rivero E. Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection. Journal of Pharmaceutical and Biomedical Analysis. 2018 Jun 5;155:235-240. doi: 10.1016/j.jpba.2018.03.057.

 

No. ARTÍCULO
5.

Hernández-Esquivel MA, Pérez-Torres A, Romero-Romero L, Reyes-Matute A, Loaiza B, Mellado-Sánchez G, Pavón L, Medina-Rivero E, Pestell RG, Pérez-Tapia SM, Velasco-Velázquez MA. The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. Biomed Pharmacother. 2018 May;101:938-944. doi: 10.1016/j.biopha.2018.03.012.

 

No. ARTÍCULO
6.

Almagro JC, Daniels-Wells TR, Perez-Tapia SM, Penichet ML. Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. Front Immunol. 2018 Jan 4;8:1751. doi: 10.3389/fimmu.2017.01751. eCollection 2017. Review. PubMed PMID: 29379493; PubMed Central PMCID: PMC5770808.

 

 

PUBLICACIONES EN COLABORACIÓN

CLAVE. ARTÍCULO
A.

Campillo-Navarro M, Leyva-Paredes K, Donis-Maturano L, Rodríguez-López GM, Soria-Castro R, García-Pérez BE, Puebla-Osorio N, Ullrich SE, Luna-Herrera J, Flores-Romo L, Sumano-López H, Pérez-Tapia SM, Estrada-Parra S, Estrada-García I, Chacón-Salinas R. Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. Front Immunol. 2018 May 28;9:1161. doi: 10.3389/fimmu.2018.01161. eCollection 2018. PubMed PMID: 29892297; PubMed Central PMCID: PMC5985745.

CLAVE. ARTÍCULO
B.

Hurtado-Alvarado G, Becerril-Villanueva E, Contis-Montes de Oca A, Domínguez-Salazar E, Salinas-Jazmín N, Pérez-Tapia SM, Pavon L, Velázquez-Moctezuma J, Gómez-González B. The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. Brain Behav Immun. 2018 Mar;69:154-166. doi: 10.1016/j.bbi.2017.11.009. Epub 2017 Nov 15. PubMed PMID:29154957.